The chemokine receptor CCR2, a G protein-coupled receptor implicated in numerous chronic inflammatory diseases, has led to the development of various small molecule antagonists. CCR2-RA-[R] effectively displaces [125I]CCL2 from CCR2 with a pIC50 value of 6.1, while its pKD for CCR2 and CCR5 are 8.8±0.1 and 7.0±0.1 respectively[2]. CCR2-RA-[R] inhibits CCR2 non-competitively by preventing activation-associated conformational changes and the formation of the G protein-binding interface. The drug-binding pocket of CCR2-RA-[R] is notably enclosed and features a beneficial mix of hydrophobic and polar characteristics that enhance its "druggability"[3].
体外研究
The chemokine receptor CCR2, a G protein-coupled receptor implicated in numerous chronic inflammatory diseases, has led to the development of various small molecule antagonists. CCR2-RA-[R] effectively displaces [125I]CCL2 from CCR2 with a pIC50 value of 6.1, while its pKD for CCR2 and CCR5 are 8.8±0.1 and 7.0±0.1 respectively[2].
CCR2-RA-[R] inhibits CCR2 non-competitively by preventing activation-associated conformational changes and the formation of the G protein-binding interface. The drug-binding pocket of CCR2-RA-[R] is notably enclosed and features a beneficial mix of hydrophobic and polar characteristics that enhance its "druggability"[3].
搜索
![CCR2-RA-[R] 化学结构 CAS号：512177-83-2](https://file.ambeed.cn/static/upload/proimg/784/512177-83-2.png)
![CCR2-RA-[R] 3D分子结构 CAS号：512177-83-2](/static/img/lifeScience/pro-3d.png)
